307 related articles for article (PubMed ID: 25880660)
41. Diagnoses and prescription patterns among users of medications for obstructive airway diseases in Finland.
Juntunen P; Salmela P; Pakkasela J; Karjalainen J; Lehtimäki L
BMC Pulm Med; 2024 Jan; 24(1):64. PubMed ID: 38297257
[TBL] [Abstract][Full Text] [Related]
42. [Real-world analysis of obstructive respiratory tract disorders: characterization, health care and costs.].
Calabria S; Ronconi G; Dondi L; Pedrini A; Piccinni C; Esposito I; Canonica GW; Martini N
Recenti Prog Med; 2021 Apr; 112(4):285-293. PubMed ID: 33877089
[TBL] [Abstract][Full Text] [Related]
43. Use of spirometry and respiratory drugs in Manitobans over 35 years of age with obstructive lung diseases.
Anthonisen NR; Woodlrage K; Manfreda J
Can Respir J; 2005 Mar; 12(2):69-74. PubMed ID: 15785794
[TBL] [Abstract][Full Text] [Related]
44. Identifying patients with asthma in primary care electronic medical record systems Chart analysis-based electronic algorithm validation study.
Xi N; Wallace R; Agarwal G; Chan D; Gershon A; Gupta S
Can Fam Physician; 2015 Oct; 61(10):e474-83. PubMed ID: 26759847
[TBL] [Abstract][Full Text] [Related]
45. Impact of COPD diagnosis timing on clinical and economic outcomes: the ARCTIC observational cohort study.
Larsson K; Janson C; Ställberg B; Lisspers K; Olsson P; Kostikas K; Gruenberger JB; Gutzwiller FS; Uhde M; Jorgensen L; Johansson G
Int J Chron Obstruct Pulmon Dis; 2019; 14():995-1008. PubMed ID: 31190785
[No Abstract] [Full Text] [Related]
46. Severe, eosinophilic asthma in primary care in Canada: a longitudinal study of the clinical burden and economic impact based on linked electronic medical record data.
Husereau D; Goodfield J; Leigh R; Borrelli R; Cloutier M; Gendron A
Allergy Asthma Clin Immunol; 2018; 14():15. PubMed ID: 29713354
[TBL] [Abstract][Full Text] [Related]
47. Feasibility of using Clinical Practice Research Datalink data to identify patients with chronic obstructive pulmonary disease to enrol into real-world trials.
Requena G; Wolf A; Williams R; Dedman D; Quint JK; Murray-Thomas T; Pimenta JM
Pharmacoepidemiol Drug Saf; 2021 Apr; 30(4):472-481. PubMed ID: 33368820
[TBL] [Abstract][Full Text] [Related]
48. Obtaining real-world evidence: the Salford Lung Study.
New JP; Bakerly ND; Leather D; Woodcock A
Thorax; 2014 Dec; 69(12):1152-4. PubMed ID: 24603195
[TBL] [Abstract][Full Text] [Related]
49. Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease?
Tata LJ; West J; Harrison T; Farrington P; Smith C; Hubbard R
Thorax; 2003 Oct; 58(10):835-9. PubMed ID: 14514932
[TBL] [Abstract][Full Text] [Related]
50. Can medicines development improve outcomes in asthma and chronic obstructive pulmonary disease management by driving effectiveness?
Leather DA; Yates L; Svedsater H; Jacques L; Collier S; Powell D; Jones R
Respir Res; 2019 Aug; 20(1):173. PubMed ID: 31375102
[TBL] [Abstract][Full Text] [Related]
51. Asthma and COPD medicines prescription-claims: A time-series analysis of England's national prescriptions during the COVID-19 pandemic (Jan 2019 to Oct 2020).
Barrett R; Barrett R
Expert Rev Respir Med; 2021 Dec; 15(12):1605-1612. PubMed ID: 34555287
[TBL] [Abstract][Full Text] [Related]
52. Impact of abolishing prescription fees in Scotland on hospital admissions and prescribed medicines: an interrupted time series evaluation.
Williams AJ; Henley W; Frank J
BMJ Open; 2018 Dec; 8(12):e021318. PubMed ID: 30567818
[TBL] [Abstract][Full Text] [Related]
53. Could phase 3 medicine trials be tagged as pragmatic? A case study: The Salford COPD trial.
Dal-Ré R
J Eval Clin Pract; 2018 Feb; 24(1):258-261. PubMed ID: 28685913
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of the use of Swedish integrated electronic health records and register health care data as support clinical trials in severe asthma: the PACEHR study.
Franzén S; Janson C; Larsson K; Petzold M; Olsson U; Magnusson G; Telg G; Colice G; Johansson G; Sundgren M
Respir Res; 2016 Nov; 17(1):152. PubMed ID: 27842551
[TBL] [Abstract][Full Text] [Related]
55. Factors associated with lung cancer in COPD patients.
Sandelin M; Mindus S; Thuresson M; Lisspers K; Ställberg B; Johansson G; Larsson K; Janson C
Int J Chron Obstruct Pulmon Dis; 2018; 13():1833-1839. PubMed ID: 29922050
[TBL] [Abstract][Full Text] [Related]
56. A Systematic Review of Case-Identification Algorithms Based on Italian Healthcare Administrative Databases for Two Relevant Diseases of the Respiratory System: Asthma and Chronic Obstructive Pulmonary Disease.
Di Domenicantonio R; Cappai G; Di Martino M; Agabiti N; Simonato L; Canova C; Barbiellini Amidei C
Epidemiol Prev; 2019; 43(4 Suppl 2):75-87. PubMed ID: 31650808
[TBL] [Abstract][Full Text] [Related]
57. Extending the data collection from a clinical trial: The Extended Salford Lung Study research cohort.
Meeraus W; Fu Q; Mu G; Fry M; Frith L; Pimenta JM
NPJ Prim Care Respir Med; 2023 Jan; 33(1):4. PubMed ID: 36650154
[TBL] [Abstract][Full Text] [Related]
58. Effectiveness
Woodcock A; Boucot I; Leather DA; Crawford J; Collier S; Bakerly ND; Hilton E; Vestbo J
Eur Respir J; 2018 Feb; 51(2):. PubMed ID: 29467200
[TBL] [Abstract][Full Text] [Related]
59. Geographical differences in the use of oral corticosteroids in patients with severe asthma in Spain: heat map based on existing databases analyses.
Almonacid C; Fitas E; Sánchez-Covisa J; Gutiérrez H; Rebollo P
BMC Pulm Med; 2023 Jan; 23(1):3. PubMed ID: 36600236
[TBL] [Abstract][Full Text] [Related]
60. Validation of general practitioner-diagnosed COPD in the UK General Practice Research Database.
Soriano JB; Maier WC; Visick G; Pride NB
Eur J Epidemiol; 2001; 17(12):1075-80. PubMed ID: 12530765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
